Yumei Chen Selected Research

Biomarkers (Surrogate Marker)

2/2022	Diagnosis of sepsis with inflammatory biomarkers, cytokines, endothelial functional markers from SIRS patients.
1/2022	Screening Biomarkers for Systemic Lupus Erythematosus Based on Machine Learning and Exploring Their Expression Correlations With the Ratios of Various Immune Cells.
10/2021	Analysis of gut microbiota and metabolites in patients with rheumatoid arthritis and identification of potential biomarkers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yumei Chen Research Topics

Disease

14	Infections 06/2022 - 02/2014
12	Neoplasms (Cancer) 10/2022 - 01/2018
5	Adenomyosis 01/2022 - 12/2013
5	Hyperalgesia 01/2022 - 12/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2021 - 03/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
4	Acute Promyelocytic Leukemia 01/2018 - 08/2008
3	Sepsis (Septicemia) 02/2022 - 01/2018
3	Pain (Aches) 01/2022 - 12/2013
3	Residual Neoplasm 01/2022 - 07/2015
2	Multiple Myeloma 10/2022 - 01/2021
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Diamond-Blackfan Anemia (Anemia, Diamond Blackfan) 05/2022 - 01/2022
2	Carcinoma (Carcinomatosis) 02/2022 - 10/2014
2	Lymphoma (Lymphomas) 02/2022 - 01/2021
2	Necrosis 02/2022 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2022 - 01/2017
2	Insulin Resistance 01/2019 - 01/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2016 - 07/2016
2	Disease Progression 03/2011 - 02/2011
1	Melanoma (Melanoma, Malignant) 12/2022
1	Chemical and Drug Induced Liver Injury 09/2022
1	Arthritis (Polyarthritis) 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Primary Ovarian Insufficiency 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2022
1	Carcinogenesis 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2021
1	Rheumatoid Arthritis 10/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 09/2021
1	Hematologic Diseases (Blood Diseases) 09/2021
1	Human Influenza (Influenza) 03/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 07/2012
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2022 - 07/2016
4	Tamoxifen FDA LinkGeneric 01/2022 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 10/2021
3	VaccinesIBA 10/2021 - 10/2019
3	Arsenic Trioxide (Trisenox)FDA Link 01/2018 - 08/2008
3	SolventsIBA 10/2016 - 12/2013
3	CorticosteroneIBA 10/2016 - 12/2013
2	Biological ProductsIBA 12/2022 - 09/2021
2	Immunoglobulin G (IgG)IBA 06/2022 - 10/2016
2	RNA (Ribonucleic Acid)IBA 05/2022 - 01/2021
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 10/2021 - 04/2021
2	Glycoproteins (Glycoprotein)IBA 09/2021 - 01/2020
2	Subunit VaccinesIBA 08/2020 - 01/2020
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 07/2014
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 02/2011
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 03/2011
2	Peptides (Polypeptides)IBA 01/2017 - 01/2017
2	Prednisone (Sone)FDA LinkGeneric 12/2016 - 07/2015
2	CollagenIBA 07/2016 - 07/2014
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 07/2014 - 12/2013
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	B-Cell Maturation AntigenIBA 10/2022
1	daratumumabIBA 10/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 09/2022
1	Oxidants (Oxidizing Agents)IBA 09/2022
1	AntibodiesIBA 06/2022
1	Ribosomal Proteins (Ribosomal Protein)IBA 05/2022
1	Vascular Endothelial Growth Factor CIBA 02/2022
1	Interleukin-6 (Interleukin 6)IBA 02/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2022
1	Interleukin-8 (Interleukin 8)IBA 02/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2022
1	Interleukin-10 (Interleukin 10)IBA 02/2022
1	CytokinesIBA 02/2022
1	SteroidsIBA 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	BerberineIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	SolutionsIBA 01/2022
1	NectinsIBA 10/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	PleuromutilinsIBA 10/2021
1	tiamulinIBA 10/2021
1	AntigensIBA 09/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2021
1	Antiviral Agents (Antivirals)IBA 04/2021
1	NanovaccinesIBA 03/2021
1	Imatinib Mesylate (Gleevec)FDA Link 03/2021

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2004
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
3	Transplantation 01/2022 - 07/2016
2	Premedication 10/2022 - 01/2021
1	Precision Medicine 10/2022
1	Quantum Dots (Quantum Dot) 06/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2022
1	Intraperitoneal Injections 01/2022
1	Oral Administration 01/2022
1	Kidney Transplantation 12/2021